Huiguo Wang

Prof. Huiguo Wang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
MXMiaomiao Xu
Miaomiao Xu
HWHuiguo Wang
Huiguo Wang
LZLin Zhu
Lin Zhu
Acetate, propionate, and butyrate are major short-chain fatty acids (SCFAs) produced by the gut microbiota as key metabolic byproducts. These SCFAs influence skeletal muscle homeostasis and exercise performance through various mechanisms. This review explores the current knowledge on the mechanisms by which SCFAs influence muscle mass, strength, metabolism, and inflammation. Acetate enhances mitochondrial function and glucose metabolism, while butyrate supports muscle mass preservation by suppressing inflammation and autophagy. Propionate plays complex roles, aiding metabolic regulation, but potentially impairing myogenic differentiation at high concentrations. These SCFAs modulate insulin sensitivity and oxidative stress; their interactions with host energy systems and immunity significantly influence muscle health. Although their therapeutic potential is evident, further studies, especially human clinical trials, are necessary to validate their effective applications. This review synthesizes emerging evidence and outlines specific future research priorities.

20 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
MXMiaomiao Xu
Miaomiao Xu
HWHuiguo Wang
Huiguo Wang
LZLin Zhu
Lin Zhu
Obesity is a global health challenge marked by substantial inter-individual differences in responses to dietary and lifestyle interventions. Traditional weight loss strategies often overlook critical biological variations in genetics, metabolic profiles, and gut microbiota composition, contributing to poor adherence and variable outcomes. Our primary aim is to identify key biological and behavioral effectors relevant to precision medicine for weight control, with a particular focus on nutrition, while also discussing their current and potential integration into digital health platforms. Thus, this review aligns more closely with the identification of influential factors within precision medicine (e.g., genetic, metabolic, and microbiome factors) but also explores how these factors are currently integrated into digital health tools. We synthesize recent advances in nutrigenomics, nutritional metabolomics, and microbiome-informed nutrition, highlighting how tailored dietary strategies—such as high-protein, low-glycemic, polyphenol-enriched, and fiber-based diets—can be aligned with specific genetic variants (e.g., FTO and MC4R), metabolic phenotypes (e.g., insulin resistance), and gut microbiota profiles (e.g., Akkermansia muciniphila abundance, SCFA production). In parallel, digital health tools—including mobile health applications, wearable devices, and AI-supported platforms—enhance self-monitoring, adherence, and dynamic feedback in real-world settings. Mechanistic pathways such as gut–brain axis regulation, microbial fermentation, gene–diet interactions, and anti-inflammatory responses are explored to explain inter-individual differences in dietary outcomes. However, challenges such as cost, accessibility, and patient motivation remain and should be addressed to ensure the effective implementation of these integrated strategies in real-world settings. Collectively, these insights underscore the pivotal role of precision nutrition as a cornerstone for personalized, scalable, and sustainable obesity interventions.

13 November 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YWYu Wang
Yu Wang
XXXianyan Xie
Xianyan Xie
GYGaoyuan Yang
Gaoyuan Yang
ZLZiyan Li
Ziyan Li
SQShuqi Qin
Shuqi Qin
HWHuiguo Wang
Huiguo Wang
Objective: To investigate the key bioactive component of Salvia miltiorrhiza (Danshen) for repairing Achilles tendon injury and to elucidate its underlying mechanisms. Methods: A network pharmacology approach was employed to screen for common targets for Danshen in Achilles tendon repair, identifying Tanshinone IIA (Tan IIA) as the key bioactive component. Its targets were then subjected to Protein-Protein Interaction (PPI) and KEGG pathway analyses. Subsequently, a rat model of Achilles tendon injury was established. After a 4-week intervention with Tan IIA, its reparative effects were comprehensively evaluated using histological, biomechanical, immunohistochemical (IHC), and ELISA methods. Results: Network pharmacology predicted that Tan IIA acts through core targets such as AKT1 and EGFR to regulate pathways including PI3K-Akt and MAPK. In vivo experiments confirmed that, compared to the model group, Tan IIA significantly improved tissue structure (histological score, P < 0.001) and enhanced the ultimate tensile load ( P < 0.01). It also upregulated Collagen Type I (COLⅠ) expression ( P < 0.05) while downregulating Vascular Endothelial Growth Factor A (VEGFA) expression ( P < 0.01), and effectively modulated serum inflammation by decreasing IL-6 ( P < 0.01) while increasing IL-10 and TGF-β ( P < 0.05). Conclusion: Tan IIA is the key bioactive component of Salvia miltiorrhiza for repairing Achilles tendon injury. It effectively promotes the structural and functional healing of the tendon by synergistically regulating key processes such as inflammation, matrix remodeling, and angiogenesis.

14 November 2025 in Biology
Verified
Journal Article
Open access
PDF file
GYGaoyuan Yang
Gaoyuan Yang
YWYu Wang
Yu Wang
XXXianyan Xie
Xianyan Xie
ZLZiyan Li
Ziyan Li
SQShuqi Qin
Shuqi Qin
LZLin Zhu
Lin Zhu
(1) Objective: This study aimed to investigate the synergistic effect and underlying mechanisms of Total Flavonoids of Rhizoma drynariae (TFRD) in combination with Bone Marrow Mesenchymal Stem Cells (BMSCs) in the repair of tendon–bone injuries. (2) Methods: The effects of TFRD on the proliferation and migration of BMSCs were assessed using CCK-8 and scratch assays, and its potential to promote osteogenic and chondrogenic differentiation was evaluated. Concurrently, the pro-angiogenic effect of TFRD on Human Umbilical Vein Endothelial Cells (HUVECs) was observed. In vivo, a rat model of Achilles tendon–bone injury was established and animals were divided into four groups: SHAM, Model, BMSCs, and BMSCs + TFRD. After an 8-week intervention, the level of functional recovery was evaluated through histological analysis, immunohistochemistry, serum biochemical analysis, and biomechanical testing. (3) Results: A concentration of 5.0 μg/mL TFRD significantly promoted the proliferation, migration, and differentiation of BMSCs and enhanced the tube formation capacity of HUVECs. In the BMSCs + TFRD group, histological analysis revealed well-organized collagen fibers, increased cartilage deposition, and an optimized tendon–bone interface (TBI) structure. Immunohistochemistry showed upregulated expression of COL I, COL II, and SOX-9, alongside downregulated VEGFA. Furthermore, serum IL-6 levels were decreased, while IL-10 and TGF-β levels were elevated. The biomechanical properties were also significantly improved in this group. (4) Conclusions: TFRD promotes tendon–bone healing and functional recovery by enhancing BMSC functions, promoting angiogenesis, and improving the local microenvironment.

1 April 2026 in Biology of Sex Differences
Verified
Journal Article
Open access
LZLin Zhu
Lin Zhu
XXXianyan Xie
Xianyan Xie
HWHuiguo Wang
Huiguo Wang
ZCZekai Chen
Zekai Chen
Background: This study aims to investigate sex differences in the response to short-term Training Program intervention and the underlying metabolomic mechanisms among obese adolescents. Methods: A total of 98 obese adolescents underwent a 4-week, strictly controlled short-term Training Program intervention. Pre- and post-intervention measurements included body morphometry, body composition, lipid metabolism, and glucose homeostasis indicators. Plasma samples were analyzed using targeted metabolomics. Linear mixed-effects models (LMM) were employed to identify Sex-differential Responsive Metabolites, with volcano plots utilized to visualize metabolic regulation preferences between sexes. Hierarchical clustering analysis identified co-regulated metabolic modules within the Sex-differential Responsive Metabolites for pathway analysis. Partial least squares (PLS) regression models were constructed separately for males and females to identify metabolic biomarkers capable of predicting changes in clinical indicators. Results: Post-intervention, both males and females showed significant decreases in weight, body mass index (BMI), chest circumference, waist circumference, hip circumference, waist-to-hip ratio, body water, Body fat mass, fat free mass, skeletal muscle mass, body fat percentage, total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) ( P < 0.001). Additionally, HOMA-β levels significantly decreased only in females ( P = 0.01). After adjusting for developmental maturity and baseline metabolic risk, the improvements in body fat mass and body fat percentage in males were significantly greater than those in females (both P < 0.01), whereas no statistical differences were found in weight and BMI improvements ( P > 0.05). The change in HOMA-β differed significantly between sexes ( P = 0.031), with females exhibiting a more pronounced downregulation following the intervention. LMM identified 65 Sex-differential Responsive Metabolites. Hierarchical clustering revealed two co-regulated modules: Module 1 showed a strong upward trend in males but a weak response in females, significantly enriched in the linoleic acid metabolism pathway; Module 2 showed a downward trend in both sexes, but the magnitude of downregulation was more pronounced in males, significantly enriched in pathways related to amino acid catabolism and energy metabolism. PLS model analysis indicated that Sex-differential Responsive Metabolites had predictive capacity for male Fasting Blood Glucose (FBG, R 2 Y = 0.2653,Q 2 = 0.0091), female FBG (R 2 Y = 0.3552,Q 2 = 0.1321), and female LDL-c (R 2 Y = 0.3895,Q 2 = 0.1853). Conclusions: Obese adolescents exhibit significant sexual dimorphism in their response to short-term Training Program. Under the same standardized training program, males achieve greater fat reduction and appear to leverage a synergistic strategy of fatty acid oxidation and protein sparing, whereas females prioritize amino-acid network fine-tuning. Predictive modeling indicates that sex-differential metabolites can predict glucolipid improvements in females. These findings provide a scientific basis for developing sex-differential exercise prescriptions for metabolic health.

10 August 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
MXMiaomiao Xu
Miaomiao Xu
HWHuiguo Wang
Huiguo Wang
LZLin Zhu
Lin Zhu
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
Background: Long-term fluctuations in body weight may reflect changes in energy balance, illness, or intentional weight loss. However, their association with subsequent triglyceride concentrations remains uncertain. Objective: To examine the association between long-term weight variability and subsequent triglyceride concentrations while accounting for directional weight change. We also assessed the robustness of the findings to adjustment for adiposity, missing data, and socioeconomic and lifestyle covariates. Methods: We analyzed adults from the China Health and Nutrition Survey who had at least three measured weights during 1989–2006 and a triglyceride measurement in 2009. The core complete-case analysis included 5191 participants and adjusted for baseline age, sex, weight slope, number of weight measurements, and working status in 2009. Weight variability was assessed using the coefficient of variation (CV; per 1 SD increment, standardized among 9500 eligible participants) and average successive variability (ASV; per 5 kg increment). Results: In the core model, each 1 SD increment in CV was associated with 2.7% higher triglyceride concentrations (β = 0.026, 95% CI: 0.007 to 0.045; p = 0.007). Each 5 kg increment in ASV was associated with 10.7% higher triglyceride concentrations (β = 0.102, 95% CI: 0.057 to 0.147; p < 0.001). After further adjustment for baseline BMI in the same BMI-complete sample, the corresponding estimates were 3.6% (95% CI: 1.7% to 5.6%) and 5.6% (95% CI: 1.0% to 10.3%), respectively. Multiple imputation yielded similar estimates. A four-knot restricted cubic spline analysis supported an overall association between CV and triglyceride concentrations (p = 0.016), with no strong evidence of nonlinearity (p = 0.101). Marginal standardization yielded adjusted differences in arithmetic mean triglyceride concentrations of 0.048 mmol/L per 1 SD increment in CV and 0.200 mmol/L per 5 kg increment in ASV. Conclusions: Greater long-term weight variability was associated with modestly higher subsequent triglyceride concentrations. Because of the observational design, the heterogeneous causes of weight change, and the possibility of residual confounding, the findings should not be interpreted as causal or independent of obesity.